{"id":334237,"date":"2010-02-18T06:40:13","date_gmt":"2010-02-18T11:40:13","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=63880"},"modified":"2010-02-18T06:40:13","modified_gmt":"2010-02-18T11:40:13","slug":"another-setback-for-cadence-stimulus-funds-help-fuel-life-sciences-jobs-tioga-gets-more-funding-for-drug-trial-more-san-diego-life-sciences-news","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/334237","title":{"rendered":"Another Setback for Cadence, Stimulus Funds Help Fuel Life Sciences Jobs, Tioga Gets More Funding for Drug Trial & More San Diego Life Sciences News"},"content":{"rendered":"\n
Life Sciences<\/a>, Venture Capital<\/a>, Roundup<\/a><\/div>\n

\t\tDenise Gellene wrote:<\/strong><\/p>\n

Some local biotechnology companies landed funding deals during the past week. We’ve got that and other highlights below.<\/p>\n

—Tioga Pharmaceuticals raised $18 million in private equity <\/a>to fund a late-stage clinical trial of asimadoline, its experimental drug for irritable bowel disorder.<\/p>\n

—San Diego received $4.95 million of $225 million in stimulus funding <\/a>awarded nationwide to increase educational, training, and placement services for people seeking local life sciences and health care jobs.<\/p>\n

—The FDA told Cadence Pharmaceuticals (NASDAQ: CADX<\/a>)\u00a0it found production problems at the contract manufacturing plant <\/a>that produces Cadence’s intravenous form of acetaminophen, a situation that must be rectified before the drug can be approved.<\/p>\n

—Carlsbad, CA-based Verdezyne raised $9 million in an ongoing $15.2 million venture round<\/a>. The industrial biotechnology company will use the funds to validate its technology for making adipic acid, a key feedstock chemical for production of nylon.<\/p>\n

—There was some good news <\/a>for a change from Sequenom (NASDAQ: SQMN<\/a>), which said it launched a non-invasive fetal sex determination test.<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

\t \t\t

\n

\n\"\"<\/a>
\n\"\"<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Life Sciences, Venture Capital, Roundup Denise Gellene wrote: Some local biotechnology companies landed funding deals during the past week. We’ve got that and other highlights below. —Tioga Pharmaceuticals raised $18 million in private equity to fund a late-stage clinical trial of asimadoline, its experimental drug for irritable bowel disorder. —San Diego received $4.95 million of […]<\/p>\n","protected":false},"author":2918,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-334237","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/334237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/2918"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=334237"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/334237\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=334237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=334237"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=334237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}